NNMT overexpression is associated with obesity and insulin resistance
Across the cagrilintide clinical program, the dominant tolerability issues have been gastrointestinal: nausea, reduced appetite, constipation, and, less commonly, vomiting a profile shared with pramlintide and with GLP-1 agonists, and mechanistically expected from a compound that slows the stomach and engages the area postrema
Claims that 'stable' forms of BPC 157 can withstand the variable environments encountered outside refrigeration or lyophilised storage settings are often overstated
Niacinamida Auxilia na funo de barreira da pele, reduz inflamao, melhora a uniformidade e contribui para uma pele mais resistente e equilibrada
Janvier, S., Cheyns, K., Canfyn, M., Goscinny, S., De Spiegeleer, B., Vanhee, C., & Deconinck, E
PMID: 34714971